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Introduction
Mitosis is a process that results in the segregation of sister
chromatids into two newly made cells. During anaphase, sister
chromatids synchronously lose cohesion, allowing the replicated
chromosomes to segregate to opposite ends of the cell. Separase
(official protein symbol ESPL1 for extra spindle poles-like 1) is
the key regulator for this segregation. This cysteine protease
cleaves the cohesin subunit SCC1-RAD21, which opens the cohesin
ring and causes it to dissociate from chromosomes. In vertebrates,
separase activation is regulated by both securin (PTTG1 or pituitary
tumor-transforming protein 1) and phosphorylation-dependent
CCNB1 (cyclin B1) binding (Gorr et al., 2005; Stemmann et al.,
2001). Securin is a chaperone protein, which, following
chromosome alignment, is ubiquitylated and degraded, leaving
separase unbound and active (Hagting et al., 2002; Zou et al., 1999).
Securin is degraded by the 26S proteasome at the metaphase-to-
anaphase transition via the anaphase-promoting complex/cyclosome
(APC/C). APC/C is an E3 ubiquitin ligase that requires the
additional function of CDC20 (Cell division cycle protein 20
homologue) or CDH1 (CD20 homologue 1) – two WD40 adaptor
proteins (Wasch and Engelbert, 2005). Moreover, securin is
degraded not only via APC/C; we have recently demonstrated that
some phosphorylated forms of securin are also degraded by the
proteasome by the action of the SKP1–CUL1–F-box protein (SCF)
complex (Gil-Bernabe et al., 2006). The SCF complex is the other
major ubiquitin ligase responsible for the specific ubiquitylation of
many regulators of the cell cycle. The receptor component of the
SCF complex is one of many F-box proteins, three of which – SKP2,
FBW7 and βTrCP – are well characterized.
There is much evidence that securin is important for other cellular
functions (Bernal et al., 2002; Ishikawa et al., 2001; Romero et al.,
2001). We previously described the role of human securin in cell-
cycle arrest after UV irradiation, when it probably prevents cell
proliferation during DNA damage repair (Romero et al., 2004).
Irradiation causes rapid proteasome-dependent securin degradation
and inhibition of specific securin protein synthesis. Thus, it is
possible that the presence of securin and its further degradation are
necessary conditions to arrest cell proliferation.
In this paper, we revisited securin degradation after UV
irradiation, using siRNA, dominant-negative mutants,
coimmunoprecipitation experiments, immunofluorescence
microscopy, in vivo ubiquitylation assays and point mutations. We
found that the proteasome-dependent securin degradation after UV
irradiation is mediated by the SCFβTrCP ubiquitin ligase, and is
prevented by GSK-3β inhibitors. Furthermore, we identified an
unconventional motif for βTrCP in securin that is responsible for
its degradation. Given that securin overexpression provokes tumor
formation and that the protein is highly expressed in many tumors
(Saez et al., 1999; Saez et al., 2006; Saez et al., 2002), the knowledge
of mechanisms that regulate its stability may help to understand
how deregulation of securin is involved in cell transformation.
Results
UV radiation induces securin degradation in both nucleus and
cytoplasm
To understand the mechanism involved in securin degradation after
UV irradiation, we first studied the subcellular localization of securin
and analyzed its loss after irradiation. As securin is degraded in
interphase after exposure to UV, and expression of the protein is
null or minimal in G1 (Romero et al., 2004), we biochemically
synchronized HeLa cells in S and G2 phases, and detected securin
expression by immunofluorescence in control and irradiated cells.
Securin is a chaperone protein with bifunctional properties. It
binds to separase to inhibit premature sister chromatid
separation until the onset of anaphase, and it also takes part in
cell-cycle arrest after UV irradiation. At metaphase-to-anaphase
transition, securin is targeted for proteasomal destruction by
the anaphase-promoting complex or cyclosome (APC/C),
allowing activation of separase. However, although securin is
reported to undergo proteasome-dependent degradation after
UV irradiation, the ubiquitin ligase responsible for securin
ubiquitylation has not been well characterized. In this study,
we show that UV radiation induced a marked reduction of
securin in both the nucleus and cytoplasm. Moreover, we show
that GSK-3β inhibitors prevent securin degradation, and that
CUL1 and βTrCP are involved in this depletion. We also
confirmed that SKP1-CUL1-βTrCP (SCFβTrCP) ubiquitylates
securin in vivo, and identified a conserved and unconventional
βTrCP recognition motif (DDAYPE) in the securin primary
amino acid sequence of humans, nonhuman primates and
rodents. Furthermore, downregulation of βTrCP caused an
accumulation of securin in non-irradiated cells. We conclude
that SCFβTrCP is the E3 ubiquitin ligase responsible for securin
degradation after UV irradiation, and that it is involved in
securin turnover in nonstressed cells.
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Securin was present in both nucleus and cytoplasm of S- and G2-
arrested HeLa cells (Fig. 1A). Moreover, UV downregulation of
securin was observed in both subcellular compartments. Subcellular
fractionation studies of the same cells using anti-Raf and anti-
hnRNP C antibodies as markers, showed that securin is more
abundant in cytosolic than in nuclear extracts, as reported
(Dominguez et al., 1998), and that UV-mediated depletion of securin
occurred in the nucleus and cytoplasm (Fig. 1B), confirming the
immunofluorescence data.
APC/C activity is not involved in securin
degradation after UV exposure
In vertebrates, the APC/C ubiquitin ligase
associates with CDC20 and CDH1 activators
in a cell-cycle-dependent manner (Wasch and
Engelbert, 2005). To determine whether securin
depletion in response to UV is mediated by
APC/C, we suppressed expression of the
endogenous CDC20 and CDH1 genes, using
siRNA. HeLa cells were transiently transfected
with pSUPER-Cdc20 and pSUPER-Cdh1, and
expression of securin after UV irradiation was
analyzed by western blotting (Fig. 2A).
However, although the expression level of
securin slightly increased in control conditions,
as well as in other APC/C substrates, such as
CCNB1 (data not shown), RNA interference
of CDC20 and CDH1 did not prevent securin
degradation after UV radiation. However,
despite the fact that securin degradation
mediated by APC/C involves CDH1 or CDC20
(Zur and Brandeis, 2001), to eliminate the
possibility that securin might also bind directly
to core subunits of APC/C in a CDC20- and
CDH1-independent manner, we inactivated
APC/C using a pool of three target-specific
siRNAs designed to knock down
CDC27/APC3 expression. APC/C contains at
least 10 different, evolutionarily conserved
components, and CDC27/APC3 is one of these
core components (King et al., 1995; Lamb et
al., 1994; Sikorski et al., 1990; Tugendreich et
al., 1995). CDC27 siRNA efficiently reduced
the level of endogenous CDC27 and,
coincident with this reduction, the amount of
securin was slightly increased in nonirradiated
cells (Fig. 2B). By contrast, scrambled
sequences of siRNA (mock) had no effect on
the CDC27 level, and did not alter the level of
securin protein. However, CDC27 depletion
did not prevent securin degradation after UV
exposure. Together, these results indicate that
the APC/C ubiquitin ligase is not involved in
securin downregulation after UV irradiation.
SKP1-CUL1-βTrCP ubiquitin ligase is
involved in UV-mediated degradation of
securin
The other major class of ubiquitin ligases that
has a central role in cell-cycle regulation is the
SCF complex. We assessed whether SCF plays
a key role in securin degradation after UV
exposure. To this end, we transfected COS-7 cells with a plasmid
containing a cullin 1 (CUL1) fragment (CUL11-452), which exerts
a dominant-negative effect by forming SCF complexes lacking
RING-box protein 1 (RBX1). These mutated complexes bind to the
substrates but are unable to catalyze their ubiquitylation (Wu et al.,
2000). In fact, this truncated form of CUL1 led to an accumulation
of CDC25A (Gil-Bernabe et al., 2006), a known SCF substrate
(Donzelli et al., 2002). Transfected cells were irradiated, and securin
expression was studied by western blotting. Expression of CUL11-452
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Fig. 1. Reduction in the amount of securin after UV irradiation in the S and G2 phases of the cell cycle
occurs in both cytoplasm and nucleus. HeLa cells were synchronized in S and G2 phases, and exposed
to UV radiation where indicated. C, synchronized and nonirradiated cells. (A) Immunofluorescence
experiments using an immunoaffinity-purified polyclonal anti-securin antibody, a monoclonal anti-
CCNB1 (cyclin B) antibody and DAPI. In the merge, securin staining is shown in green, cyclin B in
red, and DAPI in blue. Original magnification 403. (B) Detection of securin in subcellular fractions
from synchronized cells. Fractions were separated by SDS-PAGE, transferred, and probed with the
indicated antibodies. Anti-Raf and anti-hnRNP C were used to control for purity of the fractions. CE,











1827βTrCP and securin degradation
was able to block securin degradation after UV irradiation (Fig.
3A). Similar results were obtained when a securin vesicular
stomatitis virus (VSV)-containing plasmid was also cotransfected
with pCDNA3-Flag-CUL11-452 to prevent difficulties in
interpretation of results because of a reduction in endogenous securin
mRNA translation after UV irradiation (Romero et al., 2004) (Fig.
3B). Therefore, the SCF complex is involved in loss of securin after
irradiation.
Of the ~70 F-box proteins identified in humans, SKP2 (S-phase
kinase-associated protein 2) and βTrCP (also known as FBW1A)
are thought to be involved in cell-cycle control. To discover
whether one of these proteins mediates securin degradation, we used
dominant-negative variants of SKP2 and βTrCP lacking the F-box
domain (Margottin et al., 1998; von der Lehr et al., 2003), which
couples F-box proteins to the SCF complexes. βTrCP, but not SKP2,
was involved in securin degradation after UV irradiation (Fig. 3).
These results were obtained on both endogenously (Fig. 3C,E) and
ectopically expressed (Fig. 3D,F) securin. Taking these results
together, we demonstrate that Skp1-Cul1-βTrCP is the ubiquitin
ligase that mediates the UV-induced degradation of securin.
βTrCP association with securin in vivo increases after UV
irradiation
To confirm that the SCFβTrCP complex is directly involved in the
ubiquitylation and degradation of securin, and does not act via an
intermediate regulator, we studied the βTrCP-securin interaction in
vivo. COS-7 cells were transfected with pCS2-HA-βTrCP, and
extracts were used to immunoprecipitate securin in the presence of
the leucine-leucine-norleucine (LLnL) proteasome inhibitor to
prevent securin degradation. Western blots revealed that HA-βTrCP
coimmunoprecipitated with securin (Fig. 4A). Securin also
coimmunoprecipitated with the dominant-negative form of βTrCP
(βTrCPΔF), and this association increased after UV irradiation (Fig.
4B). These results implicate the SCFβTrCP complex in securin
turnover in control cells, and explain the fact that UV radiation
provokes an increase of securin degradation. Indeed, as shown in
Fig. 3E, βTrCPΔF reversed the endogenous securin depletion
observed after UV irradiation and increased the level of securin
under nonirradiated conditions.
βTrCP mediates ubiquitylation of securin
Next, we tested in vivo ubiquitylation of securin by βTrCP. For this
purpose, COS-7 cells were transiently transfected with pCDNA3-
2HA-hSec and plasmids containing MT-ubiquitin or both MT-
ubiquitin and MT-βTrCP (Fig. 5A). Transfected cells were incubated
with LLnL for 4 hours, and lysed under strong denaturation
conditions favoring preservation of ubiquitylated proteins. Filters
were blotted with anti-HA to detect 2HA-hSec and its ubiquitylated
forms. Fig. 5A shows that 2HA-hSec was effectively ubiquitylated
and that ubiquitylation was strongly stimulated by βTrCP
overexpression. Furthermore, UV radiation increased ubiquitylation
of 2HA-hSec (Fig. 5B). Together, these findings demonstrate that
securin is ubiquitylated by SCFβTrCP in nonstressed cells, and that
this E3 ubiquitin ligase is responsible for securin degradation after
UV irradiation.
Identification of a new securin destruction motif
βTrCP usually recognizes a phosphorylated DSGx2-4S motif to target
proteins for ubiquitylation and further destruction (Fuchs et al.,
2004). However, many other proteins have a nonphosphorylated
DSGX2-4S-like motif (Busino et al., 2003; Kanemori et al., 2005;
Watanabe et al., 2004). In fact, alignment of βTrCP-binding sites
in recently identified substrates has led to the proposal of a revised
consensus βTrCP-binding motif: D/E/S-S/E/D-G/A-x2-4-S/E/D
(Tempe et al., 2006).
Securin does not have a DSGx2-4S motif. However, it does have
a single site in accordance with the revised consensus motif (Fig.
6A). This sequence is conserved among the three isoforms of securin
and in various mammalian species. To determine whether this
unconventional motif is responsible for the UV-induced securin
degradation, we decided to mutate Asp109 (this residue sometimes
mimics the negative charge of a phosphoserine) to Gly. COS-7 cells
were transfected with a plasmid containing this mutant, and
irradiated. The securin mutant was not degraded after UV irradiation
(Fig. 6B), in contrast to the endogenous Cdc25A protein. Therefore,
we have identified the motif necessary for securin degradation
mediated by βTrCP.
GSK-3β inhibitors prevent UV-induced securin degradation
We have previously demonstrated that the effects of UV radiation
on securin expression were reversed with caffeine, an efficient
inhibitor of cellular DNA repair (Romero et al., 2004). However,
when we tested other inhibitors in signaling pathways that could
be disrupted with caffeine (UCN-01 for ATR-Chk1 pathway, 8-Br-
cAMP for cAMP levels, and caspase inhibitors for apoptosis), we
were unable to prevent the reduction in the amount of the protein.
Fig. 2. UV-induced degradation of securin is not mediated by APC/C.
(A) HeLa cells were transiently transfected with pSUPER-Cdh1 and pSUPER-
Cdc20 or pSUPER alone, and harvested 48 hours after transfection. Where
indicated, cells were irradiated 1 hour 30 minutes before harvesting. Extracts
were Western blotted for the detection of CDH1, CDC20 and securin (hSec).
Note that the western blot for CDC20 shows three bands, the upper two (and
most prominent) of which are crossreactive and not specific to CDC20.
(B) HeLa cells were transiently transfected with siRNA oligonucleotides
against CDC27/APC3 or nonspecific control oligonucleotides (mock) and,
after 48 hours, were irradiated or left untreated, and collected 1 hour 30
minutes later. Western blots of extracts were analyzed for CDC27/APC3,











To further investigate the signaling molecules mediating
UV-induced securin degradation, the effect was assessed
of other kinase inhibitors, such as roscovitine (a potent
and selective inhibitor of the cyclin-dependent kinases),
rapamycin (an mTOR kinase inhibitor), Bis I
(bisindolylmaleimide I hydrochloride, a protein kinase
C inhibitor) and lithium chloride (a GSK-3β inhibitor).
Of these, only lithium chloride prevented the UV-induced
securin downregulation (Fig. 7A). Similar results were
obtained with cells pretreated with cycloheximide to
block protein synthesis and to prevent the interference
of UV with newly synthesized protein (data not shown).
To confirm the role of GSK-3β in securin expression after
UV irradiation, we used TDZD-8, a specific GSK-3β
inhibitor with little effect on other kinases (Martinez et
al., 2002). TDZD-8 prevented securin degradation after
UV irradiation (Fig. 7B) and revealed a phosphorylated
securin form migrating as a retarded band on SDS-
polyacrylamide gels, which was more marked after UV
irradiation. This phosphorylated form may correspond to
priming phosphorylation events that are characteristic of
GSK-3β substrates (Forde and Dale, 2007). In fact, this
retarded band disappeared after lambda protein
phosphatase treatment (Fig. 7B, right panel). Therefore,
we conclude that GSK-3β is involved in securin
degradation.
Discussion
Securin (PTTG1) has been identified as a proto-oncogene
because its overexpression induces cell transformation
in fibroblasts and tumor formation in nude mice
(Dominguez et al., 1998; Pei and Melmed, 1997).
Furthermore, the amount of securin protein in most
primary tumors is very high compared with that in normal
tissues (Saez et al., 1999; Saez et al., 2006; Saez et al.,
2002). In addition, securin is involved in the cell response
to DNA damage (Bernal et al., 2002; Romero et al., 2004;
Romero et al., 2001). In budding yeast, Pds1/securin
contributes to cell-cycle arrest in response to DNA
damage (Wang et al., 2001). In fission yeast, Cut2/securin
is essential for separase stability and for the proper repair
of DNA damaged by UV, X-ray, and γ-ray radiation
(Nagao et al., 2004). We demonstrated that in human cells
UV radiation downregulates the level of securin protein,
inducing a cell-cycle arrest (Romero et al., 2004). In that
study, we found that a securin mutant in D and KEN
boxes (hSec KAA-DM) was stable after UV exposure,
suggesting that securin degradation is mediated by
APC/C (Romero et al., 2004). However, in light of
recent results showing that some phosphorylated forms
of securin are degraded via the SCF complex (Gil-
Bernabe et al., 2006), we decided to revisit this
question. In this report, we used siRNA against several
APC/C subunits, dominant-negative variants of several
SCF proteins, coimmunoprecipitation experiments,
immunofluorescence microscopy, in vivo ubiquitylation
assays and securin point mutants, and we demonstrated
that SCFβTrCP is the E3 ubiquitin ligase responsible for
securin degradation after UV irradiation. Furthermore,
we found that GSK-3β inhibitors prevent this
degradation, suggesting that GSK-3β might be involved
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Fig. 3. SKP1-CUL1-βTrCP is the E3 ubiquitin ligase that mediates the UV-induced
degradation of securin. (A) COS-7 cells transiently transfected with pCDNA3 or
pCDNA3-Flag-CUL11-452 were irradiated (UV) or left untreated (C) 1 hour 30 minutes
before harvesting. NP40 extracts were prepared and western blotted for CUL1, Flag-
CUL11-452 and securin detection. (B) COS-7 cells were transiently transfected with the
indicated plasmids and treated as above. Western blots were probed for the presence of
CUL1, Flag-CUL11-452, securin-VSV and EGFP. The asterisk indicates an nonspecific
band. (C) COS-7 cells were transiently transfected with pCDNA3 or pCDNA3-MT-
Skp2ΔF, and irradiated (UV) or left untreated (C) 1 hour 30 minutes before harvesting.
Extracts were western blotted for SKP2, MT-SKP2ΔF, and securin detection. (D) COS-7
cells were transfected with the indicated plasmids, treated as described, and blotted with
anti-SKP2, anti-VSV, and anti-GFP. (E) COS-7 cells transiently transfected with pCS2-
HA or pCS2-HA-βTrCPΔF were left untreated (C), irradiated (UV), or treated with
okadaic acid (OA) 1 hour 30 minutes before harvesting. NP40 extracts were prepared and
western blotted for the detection of the indicated proteins. Cells treated with OA were used
as a negative control of the experiment because phosphorylated forms of securin after OA
treatment are degraded via the SCF complex (Gil-Bernabe et al., 2006), but βTrCPΔF does
not prevent this degradation. (F) Transfected COS-7 cells with the indicated plasmids were
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in securin phosphorylation and stability. At present, we do not know
why the hSec KAA-DM mutant is not destroyed after UV exposure.
It is possible that these mutations alter the structure of the protein
in such a way that it cannot be degraded.
It is known that the most (or one of the most) important role(s)
of securin is to bind to separase to inhibit its proteolytic activity
(Zou et al., 1999). In this context, it is reasonable to propose that
securin-induced tumor formation might be the result of aneuploidy
caused by defects in sister chromatid separation. In fact, both PTTG1
overexpression and PTTG1 depletion (at least transiently) are
involved in the induction of aneuploidy (Pfleghaar et al., 2005; Yu
et al., 2000).
The findings reported in this work have the additional interest that
they might contribute to explaining the increased amount of securin
in tumors, especially in low-proliferation tumors, in which securin
expression cannot be explained by the cell proliferation rate. To date,
no genomic aberrations in securin (i.e. promoter mutations or
amplification) have been detected (Kanakis et al., 2003). Perhaps an
increased stability of securin by an insufficient degradation is one of
the causes of these cancers. In fact, aberrations in removal of N-Myc,
Myc, Fos, Jun, Src or the adenovirus E1A proteins may derail the
cell cycle and result in malignant transformation (Ciechanover, 2003).
If this is so in the case of securin, its accumulation and subsequent
oncogenic activation could result from one (or both) of two distinct
mechanisms: mutations in kinases or phosphatases that alter the
phosphorylation status of securin, or mutations in the targeting
machinery involved in the securin degradation.
Direct binding of βTrCP is usually mediated by a phosphorylated
DSGx2-4S motif in ubiquitylation substrates. Securin does not have
this classical motif, but it does have a recently described motif in
which phosphorylatable serines may be substituted by acidic amino
acids (Tempe et al., 2006). Our results confirm this revisited
consensus motif, and contribute with a new motif sequence to the
set of βTrCP-binding proteins. In fact, this motif is conserved in
the securin amino acid sequence of several mammalian species.
However, it has been reported that βTrCP can bind to the entirely
nonphosphorylated βTrCP-binding motif in CDC25A (Kanemori
et al., 2005). Under our conditions, we cannot rule out the possibility
that securin is partially phosphorylated, especially on nearby
Fig. 4. Securin binds to βTrCP in vivo. (A) Anti-securin and preimmune (PI)
sera were used in immunoprecipitations from NP40 extracts of COS-7 cells
transiently transfected with pCS2-HA-βTrCP and treated with LLnL for 4
hours before harvesting. The immunoprecipitates were probed for the presence
of HA-βTrCP and securin. Lysate, lysate from LLnL-treated COS-7 pCS2-
HA-βTrCP cells. (B) COS-7 cells transiently transfected with pCS2-HA-
βTrCPΔF were left untreated (Control) or irradiated (UV) before harvesting.
Extracts were used for coimmunoprecipitation experiments. Lysate, lysate
from COS-7 pCS2-HA-βTrCPΔF cells. Asterisk indicates IgG light chains.
Fig. 5. Securin is ubiquitylated by SCFβTrCP. (A) COS-7 cells were transfected
with the indicated plasmids, and treated with LLnL for 4 hours before
harvesting. Extracts were prepared as indicated in the Materials and Methods.
Proteins were separated by SDS-PAGE, electroblotted and probed with anti-
HA and anti-GFP antibodies. (B) Transfected cells were left untreated (C) or
irradiated (UV) 1 hour 30 minutes before harvesting.
Fig. 6. Identification of a new securin destruction motif. (A) Alignment of
βTrCP-binding motifs in securin proteins of various species. The arrow
indicates Asp109 of securin (hSec1) that was mutated to Gly. (B) COS-7 cells
were transfected with the indicated plasmids, and left untreated (C) or
irradiated (UV) before harvesting. NP40 extracts were prepared and western












residues of the βTrCP-binding motif. In any case, UV radiation
exposure increases securin ubiquitylation, suggesting that UV
might induce phosphorylation of the protein. This question will be
addressed in the near future.
It seems clear that to ensure both sister chromatid separation and
cell response to UV radiation, securin functions are tightly regulated
by several mechanisms, including abundance in the cell,
phosphorylation status, subcellular localization, and even the
existence of several isoforms. In fact, all of these mechanisms may
overlap in some way.
The securin levels at each stage of the cell cycle depend on the
balance between protein synthesis and degradation. Other cell-cycle
regulators, such as the CDC25 phosphatases, are similarly
controlled. With regard to degradation, CDC25A behaves similarly
to securin, which is degraded at the end of mitosis by the proteasome
via APC/C (Donzelli et al., 2002), whereas the SCFβTrCP complex
is responsible for its degradation during S and G2 phases and in
response to DNA damage (Busino et al., 2003; Falck et al., 2001).
As alluded above, CDC25A also has a nonphosphorylated βTrCP-
binding motif (Kanemori et al., 2005). It is possible that both
proteins are simultaneously involved in the cell-cycle arrest after
UV irradiation, because to arrest proliferation, the cell machinery
could degrade both CDC25A and securin. It would also be
interesting to know whether CDC25A is a phosphatase for securin,
but, for the moment, the only identified phosphatase involved in
securin stability is PP2A (Gil-Bernabe et al., 2006). In any case,
multiple mechanisms are in place to regulate securin functions
during the normal cell cycle and after UV radiation exposure, and
a better understanding of the ubiquitylation machinery will provide
new insights into the regulatory biology of cell-cycle transitions
and the development of anticancer drugs.
Materials and Methods
Plasmids, point mutations and sequencing
pCDNA3-hSec VSV, pCDNA3-2HA-hSec, pSUPER-Cdh1, pSUPER-Cdc20,
pCDNA3 Flag-Cul1 (1-452), pCS2-HA-βTrCP, pCDNA3-MT-βTrCP, pCS2-HA-
βTrCPΔF, pCDNA3-MT-Skp2ΔF, pCW7 (pRBG4-MT-Ubiquitin) and empty vectors
were described previously (Brummelkamp et al., 2002; Gil-Bernabe et al., 2006;
Margottin et al., 1998; Romero et al., 2004; von der Lehr et al., 2003; Ward et al.,
1995; Wu et al., 2000). hSec-D109G was constructed using the Transformer Site-
Directed Mutagenesis Kit from BD Biosciences. Sequencing of point mutations was
performed on both strands with an automatic sequencer.
Cell culture, transient transfection and UV irradiation
Routinely, HeLa and COS-7 cells were grown in Dulbecco’s modified Eagle’s
medium (BioWhittaker) as described (Romero et al., 2004). HeLa cells enriched in
S or G2 phases were also obtained as previously described (Jin et al., 1998). Purity
of the phases was confirmed by flow cytometry. For some experiments, cells were
pretreated with the proteasome and calpain inhibitor Ac-LLnL-CHO (LLnL, 100
μM, Sigma), lithium chloride (LiCl, 100 mM Sigma), or TDZD-8 (100 μM
Calbiochem).
DNA constructs were transiently transfected by electroporation into COS-7 cells,
and cells were harvested 18 hours post transfection. Where indicated, cells were UV-
irradiated with 100 J/m2 and harvested 1 hour 30 minutes later (Romero et al., 2004).
Subcellular fractionation and lysis
Subcellular fractionation of HeLa cells was carried out as described (Romero et al.,
1998). Cell lysis was performed at 4°C in Nonidet P-40 (NP40) buffer. When
necessary, extracts were treated with lambda protein phosphatase (λ-PP) (Gil-Bernabe
et al., 2006). Extracts for interference experiments were prepared using an NP40
buffer with 420 mM NaCl. Protein concentration was determined using the Bradford
assay (Bio-Rad).
Western blot analysis
Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
and gels were electroblotted onto nitrocellulose membranes and probed with the
following antibodies: immunoaffinity-purified anti-securin polyclonal antibody
(Dominguez et al., 1998), anti-hnRNP C monoclonal antibody (Romero et al.,
1998), anti-HA-peroxidase monoclonal antibody (Roche), anti-VSV and anti-α-
tubulin monoclonal antibodies (Sigma), anti-Cdc20, anti-Cdc25A and anti-Cdc27
monoclonal and anti-Cul1 and anti-Raf1 polyclonal antibodies (Santa Cruz
Biotech), anti-Cdh1 and anti-cyclin B monoclonal antibodies (BD Biosciences),
and anti-GFP polyclonal antibody (Immunology Consultants Laboratory).
Peroxidase-coupled donkey anti-rabbit IgG and sheep anti-mouse IgG were
obtained from Amersham Biosciences. Immunoreactive bands were visualized
using the Enhanced Chemiluminescence Western blotting system (ECL, Amersham
Biosciences).
Coimmunoprecipitation experiments
Cell lysates (1-2 mg) were incubated with preimmune serum for 30 minutes, and
subsequently with protein-A-Sepharose beads (Amersham Biosciences) for 1 hour
at 4°C. After centrifugation, beads were discarded, and supernatants incubated for 2
hours with polyclonal anti-securin or preimmune serum, followed by protein A-
Sepharose beads for 1 hour. Beads were washed, and bound proteins were solubilized
by the addition of SDS-sample buffer heated at 95°C for 5 minutes.
In vivo ubiquitylation assays
COS-7 cells were transfected and treated with LLnL 4 hours before harvesting. Next,
cells were washed in PBS, lysed at 95°C for 15 minutes in NP40 buffer supplemented
with 5% SDS and 10 mM iodoacetamide, and diluted in NP40 buffer supplemented
with 10 mM iodoacetamide. Proteins were separated by SDS-PAGE, and gels were
electroblotted onto nitrocellulose membranes and probed with anti-HA and anti-GFP
antibodies.
Small interfering RNA (siRNA) assays
We used pSUPER-Cdh1 and pSUPER-Cdc20 to suppress the expression of the
endogenous CDH1 and CDC20 genes (Brummelkamp et al., 2002). HeLa cells were
transiently transfected by electroporation, and harvested 48 hours post-transfection.
Reduction of protein levels was confirmed by western blotting.
To inhibit CDC27/APC3, we used synthetic siRNA oligonucleotides. In this case,
transient transfection of HeLa cells was carried out with 100 nM CDC27 siRNAs or
a nonspecific control pool (Santa Cruz Biotech), using the Oligofectamine method
as described by the manufacturer for adherent cells (Invitrogen). 48 hours after
transfection, cells were irradiated or left untreated, collected 1 hour 30 minutes later,
and analyzed for CDC27/APC3 and securin expression.
Immunofluorescence microscopy
HeLa cells were grown on coverslips, biochemically arrested in S and G2
phases, and irradiated or not with 100 J/m2. Control nonirradiated cells were
harvested at the point of UV irradiation, and irradiated cells were harvested 1 hour
30 minutes after treatment. Cells were fixed with 4% paraformaldehyde, and
permeabilized with 0.1% Triton X-100. Immunostaining was carried out according
to standard protocols. Epifluorescence microscopy was performed using a Leica
microscope.
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Fig. 7. GSK-3β inhibitors reverse the effect of UV radiation on securin
expression. HeLa cells were left untreated (C) or UV-irradiated (UV) in the
presence or absence of LiCl (A) or TDZD-8 (B). Inhibitors were added 1 hour
before irradiation. Where indicated, extracts were treated with λ-PP. Equal
amounts of extracts were resolved by SDS-PAGE. Immunoblotting was
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